glutathione in ovarian cancer a double-edged sword Role of SLC7A11/xCT Reactive oxygen species: Janus-faced molecules
Reactive oxygen species: Janus faced molecules in the era of modern cancer therapy Journal for ImmunoTherapy of Cancer Frontiers Targeting ferroptosis: a promising avenue for ovarian cancer treatment Frontiers Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy Frontiers The versatile utility of cysteine as a target for cancer treatment Frontiers Ferroptosis: a dual edged sword in tumour growth
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




